Indaptus Therapeutics Inc...

NASDAQ: INDP · Real-Time Price · USD
7.57
-0.24 (-3.07%)
At close: Aug 15, 2025, 3:10 PM

Indaptus Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
5.79M 13.36M 9.63M 39.13M
Short-Term Investments
n/a n/a 16.81M n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
638.25K 754.73K 738.25K 16.48K
Receivables
n/a n/a n/a 21.06K
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a 148.4K
Total Current Assets
6.62M 14M 27.24M 40.39M
Property-Plant & Equipment
82.17K 173.94K 81.31K 172.89K
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
720.43K 928.67K 819.56K 189.37K
Total Assets
7.34M 14.92M 28.06M 40.58M
Account Payables
870.23K 806K 1.38M 2.54M
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 80.49K 96.47K
Other Current Liabilities
n/a 1.21M 1.26M -194.18K
Total Current Liabilities
3.39M 2.77M 3.43M 4.6M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a 73.35K n/a 72.86K
Total Liabilities
3.39M 2.85M 3.43M 4.68M
Total Debt
84.16K 175.05K 80.49K 169.33K
Common Stock
120.14K 84.01K 84.01K 82.59K
Retained Earnings
-60.44M -45.42M -29.99M -15.67M
Comprehensive Income
n/a n/a 96.43K n/a
Shareholders Equity
3.94M 12.08M 24.63M 35.9M
Total Investments
n/a n/a 16.81M n/a